title: Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
abstract: To test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Mycobacterium tuberculosis (Mtb), we compared three immunization regimes designed to induce preferentially each subset. BALB/c mice were immunized intranasally (i.n.) or parenterally with antigen 85A either in a recombinant Adenoviral vector (Ad85A), as recombinant protein (r85A) or as a set of overlapping 15mer peptides (p85A). For the first time we show that i.n. immunization with overlapping 85A synthetic peptides as well as Ad85A or r85A can provide protection against Mtb challenge. For all forms of the antigen, i.n. induces greater protection against Mtb challenge than parenteral immunization. Ad85A induces a predominantly CD8T cell response against the 85A(70-78) epitope, r85A a CD4 response to 85A(99-118) and p85A a balanced CD4/CD8 response to the CD4 85A(99-118 )and CD8 85A(145-152) epitopes. Immune responses to CD4 85A(99-118) and CD8 85A(70-78) but not CD8 85A(145-152) are protective. Although Ad85A induces a strong response to the protective CD8 85A(70-78) epitope, we could not induce any response to this epitope by peptide immunization. These results show that although peptide immunization can induce protective immunity to Mtb challenge, it can also induce a response to a non-protective epitope in antigen 85A, indicating that the specificity of an immune response may be more important for protection against Mtb than its magnitude. These findings have important implications for the application of such vaccines in humans.
authors.affiliation: University of Oxford, The Peter Medawar Building for Pathogen Research, South Parks Road, Oxford OX1 3SY, UK. Electronic address: elma.tchilian@ndm.ox.ac.uk.
authors.forename: Elma
authors.initials: E
authors.lastname: Tchilian
authors.forename: Diksha
authors.initials: D
authors.lastname: Ahuja
authors.forename: Ariann
authors.initials: A
authors.lastname: Hey
authors.forename: Shisong
authors.initials: S
authors.lastname: Jiang
authors.forename: Peter
authors.initials: P
authors.lastname: Beverley
mesh_terms: D000217:Acyltransferases / Q000008:administration & dosage / Q000276:immunology*; D000281:Administration, Intranasal; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004195:Disease Models, Animal; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D014376:Tuberculosis / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000008:administration & dosage / Q000276:immunology*; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D018984:Epitopes, T-Lymphocyte; D032581:Tuberculosis Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; D000217:Acyltransferases; C112580:antigen 85A, Mycobacterium tuberculosis
keywords: Adenovirus; Antigen 85A; Epitopes; Subunit vaccine; Tuberculosis
references.citation: Eur J Immunol. 2006 Dec;36(12):3346-55
references.pmid: 17109467
references.citation: J Immunol. 2008 Oct 1;181(7):4955-64
references.pmid: 18802099
references.citation: Science. 2013 May 24;340(6135):1237874
references.pmid: 23704576
references.citation: Infect Immun. 1998 Apr;66(4):1527-33
references.pmid: 9529077
references.citation: Mucosal Immunol. 2013 May;6(3):612-25
references.pmid: 23131783
references.citation: Infect Immun. 1994 Sep;62(9):3679-87
references.pmid: 7520418
references.citation: Vaccine. 2012 Apr 16;30(18):2811-23
references.pmid: 22387630
references.citation: Am J Respir Crit Care Med. 2010 Apr 15;181(8):862-72
references.pmid: 20019338
references.citation: J Pharm Sci. 2011 May;100(5):1856-65
references.pmid: 21374619
references.citation: Mucosal Immunol. 2013 Sep;6(5):972-84
references.pmid: 23299616
references.citation: Science. 2003 Apr 11;300(5617):339-42
references.pmid: 12690202
references.citation: PLoS One. 2009 Dec 09;4(12):e8235
references.pmid: 20011050
references.citation: J Biol Chem. 2009 Apr 3;284(14):9184-91
references.pmid: 19193636
references.citation: Science. 2003 Apr 11;300(5617):337-9
references.pmid: 12690201
references.citation: J Clin Invest. 2012 Jan;122(1):303-14
references.pmid: 22133873
references.citation: Infect Immun. 2011 Aug;79(8):3328-37
references.pmid: 21628524
references.citation: Infect Immun. 2003 Jan;71(1):483-93
references.pmid: 12496199
references.citation: PLoS One. 2010 Jun 28;5(6):e11319
references.pmid: 20596522
references.citation: Lancet. 2013 Mar 23;381(9871):1021-8
references.pmid: 23391465
references.citation: Science. 1958 Nov 21;128(3334):1282-3
references.pmid: 13602798
references.citation: Infect Immun. 2007 Aug;75(8):4105-15
references.pmid: 17526747
references.citation: Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22213-8
references.pmid: 21135247
references.citation: Tuber Lung Dis. 1999;79(4):251-9
references.pmid: 10692994
references.citation: PLoS One. 2012;7(6):e39909
references.pmid: 22768165
references.citation: J Immunol. 2003 Aug 1;171(3):1602-9
references.pmid: 12874255
references.citation: Res Vet Sci. 1995 Jul;59(1):10-6
references.pmid: 8525078
references.citation: Protein Expr Purif. 2000 Feb;18(1):95-9
references.pmid: 10648174
references.citation: Nat Genet. 2010 Jun;42(6):498-503
references.pmid: 20495566
references.citation: PLoS One. 2011;6(11):e27477
references.pmid: 22110657
references.citation: Am Rev Respir Dis. 1973 Mar;107(3):351-8
references.pmid: 4632221
references.citation: J Immunol. 2004 Nov 15;173(10):6357-65
references.pmid: 15528375